CN1283235C - 清澈稳定的丙泊酚组合物 - Google Patents

清澈稳定的丙泊酚组合物 Download PDF

Info

Publication number
CN1283235C
CN1283235C CNB018225349A CN01822534A CN1283235C CN 1283235 C CN1283235 C CN 1283235C CN B018225349 A CNB018225349 A CN B018225349A CN 01822534 A CN01822534 A CN 01822534A CN 1283235 C CN1283235 C CN 1283235C
Authority
CN
China
Prior art keywords
compositions
anesthetis
parenteral
clear
propofol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018225349A
Other languages
English (en)
Chinese (zh)
Other versions
CN1489457A (zh
Inventor
S·A·排
S·H·里范卡尔
S·S·科查雷卡尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bharat Serums and Vaccines Ltd
Original Assignee
Bharat Serums and Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums and Vaccines Ltd filed Critical Bharat Serums and Vaccines Ltd
Publication of CN1489457A publication Critical patent/CN1489457A/zh
Application granted granted Critical
Publication of CN1283235C publication Critical patent/CN1283235C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB018225349A 2000-12-07 2001-12-05 清澈稳定的丙泊酚组合物 Expired - Fee Related CN1283235C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (enExample) 2000-12-07 2000-12-07
IN1106/MUM/2000 2000-12-07

Publications (2)

Publication Number Publication Date
CN1489457A CN1489457A (zh) 2004-04-14
CN1283235C true CN1283235C (zh) 2006-11-08

Family

ID=11097320

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018225349A Expired - Fee Related CN1283235C (zh) 2000-12-07 2001-12-05 清澈稳定的丙泊酚组合物

Country Status (13)

Country Link
US (1) US20040235964A1 (enExample)
EP (1) EP1351669B1 (enExample)
CN (1) CN1283235C (enExample)
AT (1) ATE279917T1 (enExample)
AU (1) AU2002217418A1 (enExample)
CA (1) CA2432549A1 (enExample)
DE (1) DE60106647T2 (enExample)
ES (1) ES2231583T3 (enExample)
IN (1) IN188917B (enExample)
MX (1) MX228228B (enExample)
RU (1) RU2257892C2 (enExample)
WO (1) WO2002045709A1 (enExample)
ZA (1) ZA200304981B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
RS54275B1 (sr) 2002-07-29 2016-02-29 Transform Pharmaceuticals, Inc. Vodeni 2,6-diizopropilfenol farmaceutski sastavi
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
EP1713444A4 (en) 2004-02-13 2012-06-20 Bioavailability Inc MICROEMULSION PREPARATION OF HIGHLY CONCENTRATED PROPOFOL FOR APPLICATIONS IN ANESTHESIA
CA2580202A1 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
MX2010010050A (es) * 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
AT514764A1 (de) * 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung
US11266621B1 (en) * 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
ATE370726T1 (de) * 1998-02-10 2007-09-15 Sicor Inc Propofolhaltiges arzneimittel enthaltend sulfite
ES2232195T3 (es) * 1999-01-28 2005-05-16 Dinesh Shantilal Patel Solucion parenteral de propofol (2,6-diisopropilfenol) y 2,5-di-o-metil-1,4;3,6-dianhidro-d-glucitol como solvente.
JP2003502363A (ja) * 1999-06-21 2003-01-21 コンイル ファーマシューティカル カンパニー、リミテッド プロポフォールを含有する静脈内注射用麻酔剤組成物
IN187686B (enExample) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
JP2004536026A (ja) * 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤

Also Published As

Publication number Publication date
ATE279917T1 (de) 2004-11-15
US20040235964A1 (en) 2004-11-25
HK1064954A1 (en) 2005-02-08
CN1489457A (zh) 2004-04-14
IN188917B (enExample) 2002-11-23
EP1351669B1 (en) 2004-10-20
WO2002045709A1 (en) 2002-06-13
DE60106647D1 (de) 2004-11-25
RU2257892C2 (ru) 2005-08-10
EP1351669A1 (en) 2003-10-15
CA2432549A1 (en) 2002-06-13
MXPA03006054A (es) 2003-09-10
MX228228B (es) 2005-06-01
ES2231583T3 (es) 2005-05-16
ZA200304981B (en) 2004-04-23
AU2002217418A1 (en) 2002-06-18
DE60106647T2 (de) 2005-11-10

Similar Documents

Publication Publication Date Title
AU710143B2 (en) Oil in water emulsions containing propofol and edetate
EP2612655A1 (en) Liquid compositions of insoluble drugs and preparation methods thereof
CN1489457A (zh) 清澈稳定的丙泊酚组合物
EP1539122A2 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
CN1917858A (zh) 麻醉用高浓度异丙酚微乳制剂
JP2013508312A (ja) ｐＨ調節剤を含むタキサンの医薬溶液、およびその作製方法
CN1416337A (zh) 麻醉制剂
KR20170071467A (ko) 동결 융해를 견딜 수 있는 지방 유제에 고농도 글리세린의 응용
CN1655824A (zh) 基于聚氧乙烯蓖麻油的稳定药物制剂及其生产方法
FI99080C (fi) Menetelmä ruoansulatuskanavan ulkopuoliseen annosteluun tarkoitettujen emulsioiden valmistamiseksi
JP2019210222A (ja) 水中油型乳化組成物及びその製造方法
CN1630524A (zh) 非肠道顺铂乳剂
CN1151782C (zh) 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
HK1064954B (en) Clear propofol compositions
EP1906921B1 (en) Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation
CN1106192C (zh) 含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
CN101032468A (zh) 一种长循环脂肪乳丙泊酚制剂
AU2017301645A1 (en) Curcumin-based pharmaceutical compositions and methods for fabricating thereof
CN1267090C (zh) 大蒜素注射乳剂及其制备方法
CN108653204B (zh) 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法
WO2025182623A1 (ja) 水および油難溶性薬物含有乳剤およびその製造方法
EP1556022A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
WO2020017578A1 (ja) オキシカム系薬物含有注射剤
CN1813690A (zh) 细辛脑注射乳剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1064954

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061108

Termination date: 20100105